U.S. Markets open in 24 hrs, 31 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,451.19 | -128.00 | -1.49% |
| NASDAQ | 1,649.51 | 4.39 | 0.27% |
| S&P 500 | 899.22 | -10.70 | -1.18% |
| Day Low 10:05 AM EDT | 3.25 | |
|---|---|---|
| Day High 09:31 AM EDT | 4.244 |
|
| Range | 0.99 | |
| Volume | 151,413 | |
| 30-Day Avg. Vol. | 281,000 |
|
| Difference | -46.12% | |
| Market Cap. | 150.81 M | |
| Change | -12.67 M | |
| Shares Out. | 40.87 M | |
| Percent Traded | 0.37% | |
| Revenue (LFY) | 18.38 M | |
| Earnings (TTM) | -20.12 M | |
| Next Earnings | 10/30/2008 |
|
| EPS (TTM) | -0.47 |
| 52-Wk Low 10/22/07 | 1.22 | |
|---|---|---|
| 52-Wk High 8/25/08 | 7.74 |
|
| Range | 6.52 | |
| Prev. Close 10/9/08 | 4.00 | |
| Today's Open | 4.10 | |
| Change | 2.50% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 2.7934 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Micromet is hoping that a new name and a second language will give it a fresh start in its war against diseases. The drug development firm is the result of the 2006 merger of CancerVax and Germany's Micromet ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.123 3/31/08 | -0.14 3/31/08 |
-0.017
Missed
|
| Last Quarter | -0.134 6/30/08 | -0.21 6/30/08 |
-0.076
Missed
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 8.45 M | 18.38 M |
| Gross Profit | — | 15.19 M |
| Operating Income | -5.92 M | -25.24 M |
| Net Income | -8.63 M | -20.13 M |
